Lung-Function Response To Tiotropium plus Olodaterol In Patients With COPD With β-Agonist Reversibility

被引：0
|
作者：
Tashkin, D. P. [1 ]
Ferguson, G. T. [2 ]
Clerisme-Beaty, E. [3 ]
Vob, F. [4 ]
Buhl, R. [5 ]
机构：
[1] Univ Calif Los Angeles, David Geffen Sch Med, Los Angeles, CA 90095 USA
[2] Pulm Res Inst Southeast Michigan, Farmington Hills, MI USA
[3] Boehringer Ingelheim Pharmaceut Inc, Ridgefield, CT USA
[4] Boehringer Ingelheim Pharma GmbH & Co KG, Ingelheim, Germany
[5] Mainz Univ Hosp, Dept Pulm, Mainz, Germany
来源：
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE | 2016年 / 193卷
关键词：
D O I：
暂无
中图分类号：
R4 [临床医学];
学科分类号：
1002 ; 100602 ;
摘要：
A6808
引用
收藏
页数：2
相关论文
共 50 条
  • [11] Tiotropium/Olodaterol improves the Quality of Life and Lung Function
    Jaeger-Becker, Dagmar
    PNEUMOLOGIE, 2016, 70 (01): : 66 - 66
  • [12] Tiotropium/Olodaterol Delivered via the Respimat Improves Lung Function in COPD Patients with Optimal or Suboptimal Peak Inspiratory Flow
    Mahler, D. A.
    Ferguson, G. T.
    Ludwig-Sengpiel, A.
    de la Hoz, A.
    Ritz, J.
    Shaikh, A.
    Watz, H.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2021, 203 (09)
  • [13] EFFICACY AND SAFETY OF TIOTROPIUM/OLODATEROL IN PATIENTS WITH COPD BY ATS CATEGORY
    不详
    THORAX, 2016, 71 : A273 - A273
  • [14] EFFICACY AND SAFETY OF TIOTROPIUM/OLODATEROL IN PATIENTS WITH COPD BY ATS CATEGORY
    Maltais, F.
    Pizzichini, E.
    Groenke, L.
    Voss, F.
    Derom, E.
    THORAX, 2016, 71 : A252 - A253
  • [15] IMPACT OF THE 2017 GOLD STRATEGY ON TIOTROPIUM plus OLODATEROL RESPONSE
    Langton, D.
    Ferguson, G.
    Voss, F.
    Maltais, F.
    Groenke, L.
    Buhl, R.
    Watz, H.
    RESPIROLOGY, 2018, 23 : 90 - 90
  • [16] Tiotropium/olodaterol versus tiotropium in Japanese patients with COPD: results from the DYNAGITO study
    Ichinose, Masakazu
    Nishimura, Masaharu
    Akimoto, Manabu
    Kurotori, Yasuhiro
    Zhao, Yihua
    de la Hoz, Alberto
    Mishima, Michiaki
    INTERNATIONAL JOURNAL OF CHRONIC OBSTRUCTIVE PULMONARY DISEASE, 2018, 13 : 2147 - 2156
  • [17] ANALYSIS OF THE EFFICACY AND SAFETY OF THE COMBINATION OF TIOTROPIUM plus OLODATEROL IN PATIENTS WITH COPD BY PREVIOUS USAGE OF INHALED CORTICOSTEROIDS
    Korn, S.
    Buhl, R.
    Groenke, L.
    Korducki, L.
    Amato, V. C.
    Ferguson, G. T.
    Abrahams, R.
    THORAX, 2015, 70 : A37 - A37
  • [18] Effects of acute dual bronchodilator treatment (tiotropium plus olodaterol) on cardiopulmonary interactions in hyperinflated patients with COPD
    Berton, Danilo Cortozi
    Marques, Renata Diniz
    Palmer, Brandon
    Webb, Katherine
    O'Donnell, Denis E.
    Neder, J. Alberto
    EUROPEAN RESPIRATORY JOURNAL, 2018, 52
  • [19] THE FIXED-DOSE COMBINATION OF TIOTROPIUM plus OLODATEROL HAS A RAPID ONSET OF ACTION IN PATIENTS WITH COPD
    Veale, A.
    Ferguson, G.
    Pizzichini, E.
    Flezar, M.
    Groenke, L.
    Korducki, L.
    RESPIROLOGY, 2016, 21 : 129 - 129
  • [20] Formoterol treatment plus tiotropium results in greater improvements in lung function compared with tiotropium administered alone in patients with COPD
    Tashkin, D.
    Varghese, S.
    JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2007, 119 (01) : S4 - S4
12345